Reply to Trollmann et al.: Perspective on LNP structure and simulation

A Adiran Garaizar (Drug Discovery Sciences) D David Díaz-Oviedo (Drug Discovery Sciences) N Nina Zablowsky (Lead Discovery) S Sami Rissanen (Chemical and Pharmaceutical Development, Bayer Pharmaceuticals) J Johannes Köbberling (Drug Discovery Sciences) J Jiawei Sun C Christoph Steiger (Chemical and Pharmaceutical Development, Bayer Pharmaceuticals) P Patrick Steigemann (Lead Discovery) F Florian A. Mann (Chemical and Pharmaceutical Development, Bayer Pharmaceuticals) K Katharina Meier (Drug Discovery Sciences)

Article Details

Volume / Issue Vol. 122, Issue 9
Published March 04, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (10)

A

Adiran Garaizar

Drug Discovery Sciences

D

David Díaz-Oviedo

Drug Discovery Sciences

N

Nina Zablowsky

Lead Discovery

S

Sami Rissanen

Chemical and Pharmaceutical Development, Bayer Pharmaceuticals

J

Johannes Köbberling

Drug Discovery Sciences

J

Jiawei Sun

C

Christoph Steiger

Chemical and Pharmaceutical Development, Bayer Pharmaceuticals

P

Patrick Steigemann

Lead Discovery

F

Florian A. Mann

Chemical and Pharmaceutical Development, Bayer Pharmaceuticals

K

Katharina Meier

Drug Discovery Sciences